CAS: 1589-60-2; 1-Phenylcyclohexanol

该化合物是一种替代环己醇衍生物,在环氧环的1处有一个苯基组,该化合物因其结构多功能性,在有机合成和制药研究中引起兴趣,作为制造更复杂的分子的关键中间体.其环己醇骨干为进一步功能化提供了一个稳定的框架,而该苯基组则在电动力替代或氢化反应中增强回动性.该化合物的惯性和电子特性使其在研究反应机制或设计具有定制功能的新化合物方面有用.该化合物通常在标准实验室条件下处理,因其有机性质需要适当的安全措施.

结构式图片

相似化合物

1821-24-5 6957-08-0 80770-73-6

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

cyclohexanone phenyllithium benzoic acid ethyl ester pentamethylenebis(magnesium bromide) 1-Phenylcyclohexene bis-(1-phenyl-cyclohexyl)-peroxide 5-benzoylvaleric acid 3-phenylcyclohex-2-enone

合成工艺路线路线简述

  • 合成目标产物 1-Phenylcyclohexanol 主要起始原料 Bromobenzene And Cyclohexanone
  • (文献来源)合成步骤主要原料 Bromobenzene 和 Cyclohexanone
📜1-Phenyl-1-Cyclohexyl-1-(Ethoxyethyl) Ether置于poly-P-Styryl-Acetonyltriphenylphosphonium Bromide体系中,用 甲醇 用作溶剂,化学反应 10.0H,以98%的收率获得1-苯基-1-环己醇
参考文献:乙酰基三苯基溴化phosph及其聚合物支撑的类似物作为醇作为烷基乙烯基醚的保护和脱保护催化剂
标题:乙酰基三苯基溴化phosph及其聚合物支撑的类似物作为醇作为烷基乙烯基醚的保护和脱保护催化剂
摘要:乙炔基三苯基溴化((atpb,1)和聚对苯乙烯基二苯基乙yl基溴化((a)都是有效的催化剂,可保护醇(如thp,Thf和ee醚)以及将thp,Thf和ee醚裂解为相应的醇酒精.它们可用于1°,2°和3°的醇,苯酚和酸不稳定的醇.在本研究中,Atpb和催化剂a都是极好的催化剂.它仅需要1x10-2-1.25x10-2 摩尔当量.反应中聚合物负载的催化剂a的量.
Doi:10.1016/s0040-4020(01)00558-0

海关参考信息

专利信息


专利号:US-5211889-A
优先权日:1991-08-01
标 题:Soluble highly reactive form of calcium and reagents thereof
发明人:RIEKE REUBEN D
权利人:UNIV NEBRASKA
摘要:A soluble highly reactive form of calcium, prepared from Ca(II) salts and a reducing agent in ethereal, polyethereal, or hydrocarbon solvents, is presented. This form of calcium can be used in the preparation of organocalcium reagents. The organocalcium reagents resulting from the reaction of the soluble highly reactive calcium with organic compounds containing either halide, cyanide, a 1,3-diene, or a polyunsaturated functionality, are stable, useful reagents for organic synthesis. The organocalcium halide reagents undergo Grignard-type reactions. They also undergo reactions with Cu(I) salts to form organocalcium cuprate reagents. The organocalcium cuprate reagents undergo a variety of cross-coupling reactions. The soluble highly reactive calcium reacts with 1,3-dienes to yield the corresponding 2-butene-1,4-diylcalcium complexes. These bis-organocalcium reagents can undergo dialkylation reactions with α,ω-alkylene dihalides and dichlorosilanes to form the corresponding 3-, 5-, and 6-membered ring derivatives. The soluble highly reactive calcium also reacts with organic dihalides to form mono- or diorganocalcium compounds which can be converted into a wide variety of polymers.

专利号:WO-2024182597-A1
优先权日:2023-03-02
标题 :Visible light driven co2 valorization
发明人:WEAVER JIMMIE D; SCHOCH TIM
权利人:THE BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECH COLLEGES
摘要:A method of carbamate ester synthesis wherein a first component is reacted with a cyclohexene by the addition of CO 2 , a photocatalyst, and light to produce an arylcyclohexyl carbamate ester. The first component is an amine, a carbamate salt produced from the amine, or a mixture thereof. In some embodiments, the method further includes treating the arylcyclohexyl carbamate ester with a base in the presence of an alcohol to produce an alkane carbamate ester and an arylcyclohexanol. Further, the method can include dehydrating the arylcyclohexanol in the presence of an acid to regenerate the arylcyclohexene.

专利号:US-6316437-B1
优先权日:1999-09-30
标题:Spirohydantoin compounds and uses thereof
发明人:HOFFMAN JACOB M
权利人:MERCK & CO INC
摘要:Spirohydantoin compounds and their pharmaceutically acceptable salts are disclosed. The synthesis of these compounds and their use as alpha 1a adrenergic receptor antagonists is also described. One application of these compounds is in the treatment of benign prostatic hyperplasia. These compounds are typically selective in their ability to relax smooth muscle tissue enriched in the alpha 1a receptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia can be achieved.

专利号:WO-9835955-A1
优先权日:1997-02-13
标 题 :Novel (thio)(meth)acrylate monomers, intermediate compounds for the synthesis of these monomers, polymerisable compositions and resulting polymers and optical and ophthalmologic applications thereof

专利号:CN-102838466-A
优先权日:2012-10-08
标题:Synthesis of 4-(2,3-difluoro-4-alkoxy)phenylcyclohexanone

专利号:US-5384078-A
优先权日:1991-08-01
标 题:Soluble highly reactive form of calcium and reagents thereof
发明人:RIEKE REUBEN D
权利人:UNIV NEBRASKA
摘要:A soluble highly reactive form of calcium, prepared from Ca(II) salts and a reducing agent in ethereal, polyethereal, or hydrocarbon solvents, is presented. This form of calcium can be used in the preparation of organocalcium reagents. The organocalcium reagents resulting from the reaction of the soluble highly reactive calcium with organic compounds containing either halide, cyanide, a 1,3-diene, or a polyunsaturated functionality, are stable, useful reagents for organic synthesis. The organocalcium halide reagents undergo Grignard-type reactions. They also undergo reactions with Cu(I) salts to form organocalcium cuprate reagents. The organocalcium cuprate reagents undergo a variety of cross-coupling reactions. The soluble highly reactive calcium reacts with 1,3-dienes to yield the corresponding 2-butene-1,4-diylcalcium complexes. These bis-organocalcium reagents can undergo dialkylation reactions with α,ω-alkylene dihalides and dichlorosilanes to form the corresponding 3-, 5-, and 6-membered ring derivatives. The soluble highly reactive calcium also reacts with organic dihalides to form mono- or diorganocalcium compounds which can be converted into a wide variety of polymers.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Wicha, J., Science of Synthesis, (2009) 48, 165.
摘要:Kostikov, R. R.; Khlebnikov, A. F.; Sokolov, V. V., Science of Synthesis, (2010) 47, 799.
摘要:Arzneimittel-Forschung. Drug Research., 19(1254), 1969 []
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知